Nanoparticle Immunoadjuvant Complexes Augment Germinal Center Responses to Vaccination
Advanced Science · 2026
DOI: 10.1002/advs.202517556 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Nicholas J Tursi und 21 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine and Immunotherapy Centerthe Wistar Institute, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Germinal Center, Nanoparticles, Adjuvants, Immunologic, Vaccination. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Vaccine approaches capable of eliciting enhanced germinal center (GC) responses would result in improved protective humoral immunity against infectious diseases. Here, we investigate whether a cytokine can be scaffolded onto a self‐assembling nanoparticle immunogen to enhance antigen‐specific GC responses and B cell maturation. To test this approach, we design chimeric nanoparticles bearing eOD‐GT8, a germline‐targeting HIV immunogen, and IL‐21, a canonical GC cytokine. DNA delivery of these nanoparticle immunoadjuvant complexes (GT8‐IL‐21‐NICs) drives improved serum antibody titers and antigen‐specific GC B cell responses in mice. Transcriptomic analysis of eOD‐GT8‐specific GC B cells demonstrates upregulation of selection‐associated gene signatures with GT8‐IL‐21‐NIC immunization. In mice harboring human bnAb precursor heavy and light chain genes, immunization with the GT8‐IL‐21‐NIC leads to increased antibody diversity, clonal expansion, somatic hypermutation, and the acquisition of key antibody mutations. These results highlight IL‐21 as a promising genetic adjuvant and demonstrate that NICs may be a valuable tool to improve antigen‐specific GC responses and vaccine‐induced immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vaccine and Immunotherapy Centerthe Wistar Institute, Philadelphia, Pennsylvania, USA.
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Biology Department, Saint Joseph's University, Philadelphia, Pennsylvania, USA.
- Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
ORCID-Profile: Nicholas J Tursi
Förderung
- NIAID NIH HHS
- NIH HHS
- NCI NIH HHS
- INOVIO Pharmaceuticals
- NIH IPCAVD
- W.W. Smith Charitable Trust Distinguished Professorship in Cancer Research
- Commonwealth of Pennsylvania Health Research Formula Fund
- The Jill and Mark Fishman Foundation
Zitieren
APA
Tursi, N. J., Agostino, C. J., Huang, J., Kannan, T., Laenger, N., Londregan, J., Lederer, K., Helble, M., Bedanova, N., Livingston, C., Gary, E. N., McCanna, M., Medina, M. T., Habib, R., Relaño, I. R., Maillard, I., Patel, A., Allman, D., Kossenkov, A., …, & Weiner, D. B. (2026). Nanoparticle Immunoadjuvant Complexes Augment Germinal Center Responses to Vaccination. Advanced Science. https://doi.org/10.1002/advs.202517556
Vancouver
Tursi NJ, Agostino CJ, Huang J, Kannan T, Laenger N, Londregan J, et al. Nanoparticle Immunoadjuvant Complexes Augment Germinal Center Responses to Vaccination. Advanced Science. 2026. doi:10.1002/advs.202517556
BibTeX
@article{Tursi2026,
author = {Tursi, Nicholas J and Agostino, Colby J and Huang, Jinwei and Kannan, Toshitha and Laenger, Niklas and Londregan, Jennifer and Lederer, Katlyn and Helble, Michaela and Bedanova, Nicole and Livingston, Cory and Gary, Ebony N and McCanna, Madison and Medina, Marta Tarquis and Habib, Rumi and Relaño, Ignacio Rodriguez and Maillard, Ivan and Patel, Ami and Allman, David and Kossenkov, Andrew and Escolano, Amelia and Kulp, Daniel W and Weiner, David B},
title = {Nanoparticle Immunoadjuvant Complexes Augment Germinal Center Responses to Vaccination},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202517556}
}
EUVIMED